HeartSciences (HSCS) Proxy filing summary

Executive summary

• HeartSciences and Fortitude have entered into a definitive all-stock merger agreement, combining an AI-powered medical technology company with a digital asset mining platform anchored in Zcash.

• The merger aims to create a newly public company with diversified operations in both digital assets and medical technology.

• Communications regarding the transaction include forward-looking statements subject to risks such as market volatility, regulatory uncertainty, and integration challenges.

Voting matters and shareholder proposals

• HeartSciences shareholders will be asked to vote on the approval of the proposed merger at a special meeting.

• Proxy materials, including a preliminary proxy statement, have been filed with the SEC and will be supplemented by a definitive proxy statement and proxy card.

Board of directors and corporate governance

• Directors and executive officers of both HeartSciences and Fortitude, as well as certain DCG executives, may participate in the proxy solicitation.

• Information on the interests of directors and officers in the transaction is disclosed in the proxy materials.